Multimodal data integration enables precision cancer diagnostics by aligning genomic mutations (eg, BRCA1/BRCA2), imaging features (eg, tumor size and margin irregularity), and serum biomarkers (eg, HE4 and CA125 for ovarian cancer). This evidence concerns the gene WFDC2 and cancer.